title: Evaluating advanced technologies in radiation oncology: when and how should randomized trials be done?
authors.affiliation: Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Sanguineti
authors.forename: Theodore L
authors.initials: TL
authors.lastname: DeWeese
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control*; D018787:Radiation Oncology / Q000639:trends*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016896:Treatment Outcome; D014481:United States